People with type 2 diabetes that took a GLP-1 treatment had a lower risk of developing obesity-related cancer, compared with patients that took insulin
Type 2 diabetes patients can significantly lower their risk for 10 obesity-related cancers if they take Ozempic instead of insulin to manage the disease, new research finds.
The research adds to research suggesting benefits for a growing number of health conditions and bolster the public health case for insurers to cover the treatments.
Type 2 diabetes patients on GLP-1 treatments, including Ozempic, have a lower risk of 10 types of obesity-related cancers compared to those on insulin, according to a new study.
(CNN) — GLP-1 medications such as Ozempic and Wegovy may help lower the risk of certain cancers, a new study suggests.People who are overweight or obese
Blockbuster weight loss and diabetes drugs may lower patients’ risk of developing some common types of cancer that are closely linked to obesity, new evidence suggests.
A class of diabetes medications, which include the best-selling drug Ozempic, are associated with a reduced risk of certain obesity-related cancers, according to a study released Friday.
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
Popular weight-loss and diabetes medications linked to lower risk of some cancers, study finds | Since Then
